Notice2022-27543
Advisory Commission on Childhood Vaccines Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
December 20, 2022
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Commission on Childhood Vaccines (ACCV) will hold public meetings for the 2023 calendar year (CY). Information about the ACCV, agendas, and materials for these meetings can be found on the ACCV website at https://www.hrsa.gov/advisory- committees/vaccines/index.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 243 (Tuesday, December 20, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 243 (Tuesday, December 20, 2022)]
[Notices]
[Pages 77852-77853]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-27543]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines Meeting
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Commission on Childhood Vaccines
(ACCV) will hold public meetings for the 2023 calendar year (CY).
Information about the ACCV, agendas, and materials for these meetings
can be found on the ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/index.html">https://www.hrsa.gov/advisory-committees/vaccines/index.html</a>.
DATES: The ACCV meetings will be held on:
<bullet> March 1, 2023, 10:00 a.m. Eastern Time (ET)-4:00 p.m. ET;
<bullet> March 2, 2023, 10:00 a.m. ET-4:00 p.m. ET;
<bullet> September 6, 2023, 10:00 a.m. ET-4:00 p.m. ET; and
<bullet> September 7, 2023, 10:00 a.m. ET-4:00 p.m. ET.
ADDRESSES: Meetings may be held in-person or by Zoom webinar. For
updates on how the meeting will be held, visit the ACCV website 30
business days before the date of the meeting, where instructions for
joining meetings either in-person or remotely will be posted. In-person
ACCV meetings will be held at 5600 Fishers Lane, Rockville, Maryland
20857. For meeting information updates, go to the ACCV website meeting
page at <a href="https://www.hrsa.gov/advisory-committees/vaccines/meetings.html">https://www.hrsa.gov/advisory-committees/vaccines/meetings.html</a>.
FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison,
Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane,
08N186B, Rockville, Maryland 20857; 301-945-9386; or <a href="/cdn-cgi/l/email-protection#1455575742547c6667753a737b62"><span class="__cf_email__" data-cfemail="2f6e6c6c796f475d5c4e01484059">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The ACCV provides advice and recommendations
to the Secretary of HHS (Secretary) on policy, program development, and
other
[[Page 77853]]
issues related to implementation of the National Vaccine Injury
Compensation Program and concerning other matters as described under
section 2119 of the Public Health Service Act (42 U.S.C. 300aa-19).
Since priorities dictate meeting times, be advised that start
times, end times, and agenda items are subject to change. Refer to the
ACCV website listed above for any meeting updates that may occur. For
CY 2023 meetings, agenda items may include, but are not limited to:
updates from the Division of Injury Compensation Programs, Department
of Justice, Office of Infectious Disease and HIV/AIDS Policy (HHS),
Immunization Safety Office (Centers for Disease Control and
Prevention), National Institute of Allergy and Infectious Diseases
(National Institutes of Health) and Center for Biologics, Evaluation
and Research (Food and Drug Administration). Refer to the ACCV website
listed above for all current and updated information concerning the CY
2023 ACCV meetings, including draft agendas and meeting materials that
will be posted 5 calendar days before the meeting.
These meetings are open to the public. Meetings held by Zoom
webinar will require registration. Registration details will be
provided on the ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/meetings.html">https://www.hrsa.gov/advisory-committees/vaccines/meetings.html</a>. All registrants will be asked to
provide their name, affiliation, and email address. After registration,
individuals will receive personalized Zoom information via email.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the scheduled meeting(s). Oral comments will be honored in the order
they are requested and may be limited as time allows. Requests to
submit a written statement or make oral comments to the ACCV should be
sent to Pita Gomez using the contact information above at least 5
business days before the meeting date(s).
Individuals who need special assistance or another reasonable
accommodation should notify Pita Gomez using the contact information
listed above at least 10 business days before the meeting(s) they wish
to attend. If an in-person meeting is held, it will occur in a federal
government building, and attendees must go through a security check to
enter the building. Non-U.S. citizen attendees must notify HRSA of
their planned attendance at least 20 business days prior to the meeting
in order to facilitate their entry into the building. All attendees are
required to present government-issued identification prior to entry.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-27543 Filed 12-19-22; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on December 20, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.